• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

EPZM:US

27.9950 USD 0.4050 1.47%

As of 11:15:15 ET on 10/21/2014.

Snapshot for Epizyme Inc (EPZM)

Open: 27.8800 Day's Range: 27.1500 - 28.2500 Volume: 46,739
Previous Close: 27.5900 52wk Range: 18.1000 - 42.0000 1-Yr Rtn: -24.79%

Stock Chart for EPZM

No chart data available.
  • EPZM:US 28.0350
  • 1D
  • 1M
  • 1Y
27.5900
Interactive EPZM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EPZM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4400
Est. EPS (USD) (12/2014) -1.6040
Est. PEG Ratio -
Market Cap (M USD) 927.91
Shares Outstanding (M) 33.58
30 Day Average Volume 325,323
Price/Book (mrq) 4.9273
Price/Sale (ttm) 12.2069
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EPZM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EPZM

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers, and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

Robert J GouldPresident/CEOPeter HoChief Development Officer
Eric E HedrickChief Medical OfficerRobert A CopelandExec VP/Chief Scientific Ofcr
More Company Profile & Key Executives for EPZM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil